Endothelin Receptor Type A (EDNRA) Antibody

Este producto es parte de EDNR - Endothelin Receptor
Endothelin Receptor Type A (EDNRA) Antibody
260€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Endothelin Receptor Type A (EDNRA) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx211933
Tested Applications
ELISA, WB, IHC

Description

EDNRA Antibody is a Rabbit Polyclonal against EDNRA.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Endothelin Receptor Type A (EDNRA)
Immunogen: Synthetic peptide of human EDNRA.
Host
Rabbit
Reactivity
Human, Mouse
Recommended Dilution
ELISA: 1/1000 - 1/2000, WB: 1/200 - 1/1000, IHC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS, pH 7.4, containing 0.05% NaN3 and 40% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P25101
Gene ID
1909
Alias
EDNRA,ET-AR,ENDOR,endothelin A receptor,endothelin-1 receptor,Gpcr10,ETA,ET-A,ETAR,ETRA,MFDA,ETA-R,hET-AR,Endothelin 1 Receptor
Background
Antibody anti-EDNRA
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

EDNRA is a G protein-coupled receptor (GPCR) that binds endothelin-1 (ET-1) with high affinity, playing a critical role in regulating vascular tone, cell proliferation, and cardiac function. It is predominantly expressed on vascular smooth muscle cells, where its activation by ET-1 triggers potent vasoconstriction through downstream signaling pathways, including phospholipase C (PLC), protein kinase C (PKC), and calcium mobilization. EDNRA-mediated signaling is essential for maintaining blood pressure and vascular homeostasis but contributes to pathological conditions such as hypertension, pulmonary arterial hypertension (PAH), and atherosclerosis when dysregulated. In cancer, EDNRA is overexpressed in tumors, including breast, ovarian, and prostate cancers, where it promotes cell proliferation, survival, angiogenesis, and metastasis by enhancing ET-1 signaling. EDNRA activation also contributes to cardiac hypertrophy and fibrosis in heart failure, making it a therapeutic target for cardiovascular diseases. Pharmacological antagonists of EDNRA, such as endothelin receptor antagonists (ERAs), have shown efficacy in managing PAH and reducing vascular remodeling. Overall, EDNRA plays a vital role in vascular physiology and disease, with its dysregulation driving cardiovascular pathology and tumor progression.

Productos relacionados

abx032836

Endothelin Receptor Type A (EDNRA) Antibody

EDNRA is a receptor for endothelin-1. Mediates its action by association with G proteins that activate a phosphatidylino…

Ver producto
abx119460

Endothelin Receptor Type A (EDNRA) Antibody

EDNRA Antibody is a Rabbit Polyclonal antibody against EDNRA.…

Ver producto
abx151411

Human Endothelin 1 Receptor (EDNRA) ELISA Kit

Human Endothelin 1 Receptor (EDNRA) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Endothe…

Ver producto